Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
A new preservation solution for lung transplantation : Evaluation in a porcine transplantation model. / Pizanis, Nikolaus; Petrov, Andrey; Heckmann, Jens; Wiswedel, Ingrid; Wohlschlger, Jeremias; De Groot, Herbert; Jakob, Heinz; Rauen, Ursula; Kamler, Markus.
в: Journal of Heart and Lung Transplantation, Том 31, № 3, 03.2012, стр. 310-317.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - A new preservation solution for lung transplantation
T2 - Evaluation in a porcine transplantation model
AU - Pizanis, Nikolaus
AU - Petrov, Andrey
AU - Heckmann, Jens
AU - Wiswedel, Ingrid
AU - Wohlschlger, Jeremias
AU - De Groot, Herbert
AU - Jakob, Heinz
AU - Rauen, Ursula
AU - Kamler, Markus
N1 - Funding Information: U.R. and H.d.G. are consultants of Dr. Franz Köhler Chemie GmbH (Bensheim, Germany). None of the other authors have any conflicts of interest to disclose. This study was funded in part by a grant from Dr. Franz Köhler Chemie . The design, performance, data interpretation and manuscript preparation was under the complete control of the authors and not influenced by the sponsoring company. The authors thank Karin Kaiser for excellent technical assistance. N.P. received a grant from the medical faculty of the University of Essen (IFORES Program).
PY - 2012/3
Y1 - 2012/3
N2 - Background: Lung preservation injury is still a major problem in lung transplantation. The aim of the current study was to evaluate the effects of a new preservation solution (Custodiol-N) for lung preservation. Methods: Using an in vivo pig model, 7 lungs each were preserved for 24 hours after perfusion with: low-potassium dextran (LPD) solution as control (Group I); base solution of Custodiol-N without iron chelators (Group II); Custodiol-N (Group III); or Custodiol-N supplemented with dextran 40 (Group IV). Four animals received a sham operation. After left lung transplantation and contralateral lung exclusion, hemodynamics and blood gases were monitored for 6 hours; tissue samples were taken at the end of the experiments. Results: All animals survived the transplantation procedure. Base solution and Custodiol-Npreserved lungs (Groups II and III) showed graft function similar to that of LPD-preserved lungs (Group I), showing a trend toward improved values. Custodiol-N with dextran (Group IV) led to a significant reduction of mean pulmonary arterial pressure (20 ± 2 vs 28 ± 3 mm Hg, p < 0.01) and pulmonary vascular resistance (410 ± 51 vs 588 ± 83 dyne/s/cm 5, p < 0.01), and oxygenation ratio was significantly higher (536 ± 52 vs 313 ± 107 mm Hg at 6 hours, p < 0.01) and PCO 2 values were significantly lower (51 ± 9 vs 77 ± 5 mm Hg at 6 hours, p < 0.01) at 6 hours compared with LPD (Group I). Custodiol-N (Groups II to IV) showed a trend toward a lower wet/dry ratio and reduced oxidative stress; in the presence of dextran (Group IV), the difference was again statistically significant, when compared with LPD (Group I). Conclusions: Custodiol-N solution is a new alternative preservation solution for lung transplantation that offers significantly superior protection compared with LPD when dextran 40 is added.
AB - Background: Lung preservation injury is still a major problem in lung transplantation. The aim of the current study was to evaluate the effects of a new preservation solution (Custodiol-N) for lung preservation. Methods: Using an in vivo pig model, 7 lungs each were preserved for 24 hours after perfusion with: low-potassium dextran (LPD) solution as control (Group I); base solution of Custodiol-N without iron chelators (Group II); Custodiol-N (Group III); or Custodiol-N supplemented with dextran 40 (Group IV). Four animals received a sham operation. After left lung transplantation and contralateral lung exclusion, hemodynamics and blood gases were monitored for 6 hours; tissue samples were taken at the end of the experiments. Results: All animals survived the transplantation procedure. Base solution and Custodiol-Npreserved lungs (Groups II and III) showed graft function similar to that of LPD-preserved lungs (Group I), showing a trend toward improved values. Custodiol-N with dextran (Group IV) led to a significant reduction of mean pulmonary arterial pressure (20 ± 2 vs 28 ± 3 mm Hg, p < 0.01) and pulmonary vascular resistance (410 ± 51 vs 588 ± 83 dyne/s/cm 5, p < 0.01), and oxygenation ratio was significantly higher (536 ± 52 vs 313 ± 107 mm Hg at 6 hours, p < 0.01) and PCO 2 values were significantly lower (51 ± 9 vs 77 ± 5 mm Hg at 6 hours, p < 0.01) at 6 hours compared with LPD (Group I). Custodiol-N (Groups II to IV) showed a trend toward a lower wet/dry ratio and reduced oxidative stress; in the presence of dextran (Group IV), the difference was again statistically significant, when compared with LPD (Group I). Conclusions: Custodiol-N solution is a new alternative preservation solution for lung transplantation that offers significantly superior protection compared with LPD when dextran 40 is added.
KW - dextran
KW - iron chelator
KW - ischemia/reperfusion injury
KW - lipid peroxidation
KW - lung transplantation
KW - preservation solution
KW - ROS
UR - http://www.scopus.com/inward/record.url?scp=84857058416&partnerID=8YFLogxK
U2 - 10.1016/j.healun.2011.11.009
DO - 10.1016/j.healun.2011.11.009
M3 - Article
C2 - 22226803
AN - SCOPUS:84857058416
VL - 31
SP - 310
EP - 317
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
SN - 1053-2498
IS - 3
ER -
ID: 87993937